1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Joy Hu
Joy Hu
Articles (391) 

Weekly CEO Buys Highlights

Insiders obtain shares of Tesla, Sears, PJT, Ambac, OPKO

According to GuruFocus’ Insider Data, these are the largest CEO buys during the past week. The overall trend of purchases is illustrated in the chart below:

Tesla CEO bought 95,420 shares

Tesla Inc. (NASDAQ:TSLA) CEO and 10% owner Elon Musk bought 95,420 shares for $262.00 per share on March 17. The stock price has increased by 0.44% since.

Tesla designs, develops, manufactures and sells high-performance fully electric vehicles and electric vehicle powertrain components. The company has a market cap of $42.87 billion. Its shares traded at $263.16 with a price-earnings (P/E) ratio of -56.23 as of March 24.

Revenue for the fourth quarter of 2016 was $2.28 billion compared to $1.21 billion for the prior-year period.

Director Kimbal Musk sold 2,500 shares for $253.93 per share on March 1. The stock price has increased by 3.63% since.

Sears Holdings CEO bought 525,936 shares

Sears Holdings Corp. (NASDAQ:SHLD) CEO and 10% owner Edward S. Lampert bought 525,936 shares for $7.93 per share on March 24. The stock price has increased by 7.19% since.

Sears, along with its subsidiaries, is an integrated retailer with full-line and specialty retail stores in the U.S., operating through Kmart and Sears. The company has a market cap of $910.35 million. Its shares traded at $8.50 with a P/E ratio of -0.41 as of March 24.

Sears reported a net loss of $607 million for the fourth quarter of 2016.

Director and 10% Owner Fairholme Capital Management LLC bought 281,900 shares for $8.67 per share on March 14 and 222,100 shares for $8.79 per share on March 17. Fairholme also purchased 613,900 shares for $8.17 per share on March 22. The stock price has increased by 4.04% since.

PJT Partners CEO bought 16,500 shares

PJT Partners Inc. (NYSE:PJT) Chairman and CEO Paul J. Taubman bought 16,500 shares for $36.55 per share on March 21. The stock price has decreased by 3.01% since.

PJT is an independent financial advisory firm. It provides strategic advisory, restructuring and reorganization and funds advisory services to corporations, financial sponsors, institutional investors and governments. The company has a market cap of $1.23 billion. Its shares traded at $35.45 with a P/E ratio of -213.55 as of March 24.

Total revenues for the three months ended Dec. 31, 2016 were $173.5 million compared with $103.8 million for the three months ended Dec. 31, 2015.

Director James Costos bought 2,600 shares for $38.26 per share on March 17. The stock price has decreased by 7.34% since.

General Counsel James W. Cuminale bought 7,000 shares for $38.8 per share on March 24. The stock price has decreased by 8.63% since.

Ambac Financial Group CEO bought 20,000 shares

Ambac Financial Group Inc. (NYSE:AMBC) CEO Claude Leblanc bought 20,000 shares for $19.55 per share on March 17. The stock price has decreased by 9.36% since.

Ambac is a financial services holding company and operates two reportable business segments: Financial Guarantee and Financial Services. It is a guarantor of public finance and structured finance obligations. The company has a market cap of $801.46 million. Its shares traded at $17.72 with a P/E ratio of 10.80 as of March 24.

The fourth quarter of 2016 produced a net loss of $94.7 million compared to net income of $101.5 million for the third quarter of 2016.

OPKO Health CEO bought 38,000 shares

CEO, Chairman and 10% owner of OPKO Health Inc. (OPK) Phillip Frost bought 38,000 shares for $7.93 per share during the past week.

Frost bought 1,800 shares for $8.03 per share on March 15; 9,000 shares for $8.19 per share on March 17; 11,000 shares for $7.99 per share on March 20; and 5,800 shares on March 21 for $7.85 per share. Frost also purchased 12,200 shares for $7.71 per share on March 23. The stock price has increased by 1.82% since.

OPKO is a biopharmaceutical and diagnostics company. It is engaged in the research and development of pharmaceutical products and vaccines. The company has a market cap of $4.38 billion. Its shares traded at $7.85 with a P/E ratio of -170.65 as of March 24.

Consolidated revenues for the three months ended Dec. 31, 2016 of $275.5 million were consistent with the comparable period of 2015 revenue of $276.2 million. Net loss for the three months ended Dec. 31, 2016 was $13.7 million compared with net income of $1.6 million for the 2015 period.

Senior Vice President and CFO Adam Logal sold 112,975 shares on March 14 for $8.07 per share. The stock price has decreased by 2.73% since.

For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.

Start a free seven-day trial of Premium Membership to GuruFocus.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by Joy Hu


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)